Chapters - Mexico

The creation of ISoP Mexico Chapter was announced in October 2008, during the Annual Meeting in Argentina.
ISoP Chapters Mexico


According to ISoP´s aims, this Chapter is dedicated to support Pharmacovigilance reinforcement based on educational and academic activities.

Few Mexican members continued activities from 2008 to 2011 mainly for economic reasons. We are grateful with the EC for their kind decision related to include medium income countries with a preferential membership fee, which could be helpful for maintaining Latin American members in the long term.

ISoP 12th Annual Meeting

With the great support of the Executive Committee, the 12th Annual Meeting was hosted in Cancun, Mexico in October 2012.

During the event, we were pleased to have 290 attendants from all over the world and particularly, 152 of them were from Mexico and the Latin America Region.

From now and afterwards, we will continue working in training activities addressed to all different parties involved in pharmacovigilance. We are also interested in promoting networking between regional countries and diverse organizations that are involved in safe and rational use of medications.

2013 Activities

Pharmacovigilance training for Hospitals and General Practice Clinics.

Recent changes to the national certification scheme by Mexico’s General Salubrity Council covered pharmacovigilance activities for helping Therapeutics Committees in decision making processes at local or institutional formularies, as well as promote ADRs /ADEs reporting and medication errors detection and preventing systems. ISoP’s members have been involved in training activities at hospitals, which are now generating interesting information. Preliminary data have revealed diverse risks associated to ineffectiveness of some multisource medications, harmful events from empirical or herbal compounds and from non-rational self-medication.

Proposed Training strategies

Methods in Pharmacovigilance
2-day workshop to be held in Mexico City
January, 2014


To improve capabilities and skills for detecting ADRs/ADEs, to design pharmacovigilance studies, to analyze and set up data for pharmacoepidemiology designs including pasive and active pharmacovigilance methodology.


Healthcare professionals working in pharmaceutical industry, hospitals and clinics, health authorities, clinical research professionals, academics and students from healthcare programs, decision-makers, administrators, contract research organizations (CRO’s) and all parties related with safety of medicines.

Language: Spanish
Sessions: Face to face

Discussion and analysis of selected articles or study cases

Professors: From ISoP (TBC)
Cost: (TBC) In two stratified fees:

  • Pharmaceutical Industry, CRO’S and profitable organizations
  • Academics, students, health authority and public healthcare sector

It includes: Simultaneous Translation, access to all course materials and certificate of attendance issued by the International Society of Pharmacovigilance. Coffee-breaks and lunch for 2 days.

Suggested general topics

  • The need of Pharmacovigilance
  • Causality Assessment
  • Regulatory Pharmacovigilance
  • Pharmacovigilance from the Pharmaceutical Industry approach
  • Methods in Pharmacovigilance
  • Discussion of selected articles
  • Study cases

ISoP LA Chapter 4th Symposium in Mexico City, Mexico
5th-6th December 2017 (Auditorium Hospital Angeles Acoxpa)

In collaboration with the ISoP Mexico chapter

The 4th Symposium of the ISoP Latin-America chapter took place in México city, México, on 5th and 6th December 2017 as part of educational activities organized with the aim to increase knowledge and to ensure trainings in the field of Pharmacovigilance. The venue was the Hospital Ángeles Acoxpa.
Click here for programme.
Information regarding registration (free for ISoP members), please contact Dra Raquel Herrera Comoglio at


All persons interested in pharmacovigilance activities are welcome and invited to be a member of ISoP and the Mexico Chapter, not exclusively from Mexico, all Latin American persons, healthcare professionals and representatives from patient’ organizations are also welcome through the following link: